Evidence map›Paper›PMID 40261381›Full record

ArticleIntensive care medicine2025

Visualizing the burden of brain tissue hypoxia and metabolic dysfunction assessed by multimodal neuromonitoring in subarachnoid hemorrhage patients: the TITAN study.

Elisa Gouvêa Bogossian, Bavo Kempen, Michael Veldeman, Soojin Park, Verena Rass, Stephane Marinesco, Miriam Weiss, Gerrit Alexander Schubert, Nick Kastenholz, Jan Claassen and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Intensive care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Elisa Gouvêa BogossianDepartment of Intensive Care, Hôpital Universitaire de Bruxelles-Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. elisagobog@gmail.com.ORCID 0000-0002-2062-465X
Bavo KempenDepartment of Neurosciences, KU Leuven, Leuven, Belgium.
Michael VeldemanDepartment of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.
Soojin ParkDepartment of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, USA.
Verena RassNeurological Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Stephane MarinescoUniversité Claude Bernard Lyon 1, CNRS, INSERM, Centre de Recherche en Neurosciences de Lyon CRNL U1028, UMR5292, TIGER, Bron, France.
Miriam WeissDepartment of Neurosurgery, Cantonal Hospital Aarau, Aarau, Switzerland.
Gerrit Alexander SchubertDepartment of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.
Nick KastenholzDepartment of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.
Jan ClaassenDepartment of Neurology, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, USA.
Philipp KindlNeurological Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Anna BerekNeurological Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Marco AnderloniDepartment of Intensive Care, Hôpital Universitaire de Bruxelles-Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Catharina Conzen-DilgerDepartment of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.
Sophie SchuindDepartment of Neurosurgery, Hôpital Universitaire de Bruxelles-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Baptiste BalançaUniversité Claude Bernard Lyon 1, CNRS, INSERM, Centre de Recherche en Neurosciences de Lyon CRNL U1028, UMR5292, TIGER, Bron, France.
Yannick TholanceSynaptopathies and Autoantibodies, Faculté de Médecine Jacques Lisfranc, University Jean-Monnet, University Claude Bernard Lyon 1, MeLis, CNRS UMR 5284 INSERM U1314, Institut Neuromyogène, Saint-Étienne, France.
E Sander ConnollyDepartment of Neurosurgery, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian Hospital, New York, USA.
Geert MeyfroidtLaboratory and Departement of Intensive Care Medicine, KU Leuven and University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0003-4259-3935
Raimund HelbokNeurological Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Giorgia CarraBiomedical Data Science Center and Department of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland.
Fabio Silvio TacconeDepartment of Intensive Care, Hôpital Universitaire de Bruxelles-Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Funding

Machine Learning to Optimize Management of Acute HydrocephalusR01NS131606 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Soojin Park · 2023 to 2026
$2.6M
ContinuOuS Monitoring Tool for Delayed Cerebral IsChemia (COSMIC)R01NS129760 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Soojin Park · 2023 to 2026
$2.5M
NINDS NIH HHS R01 NS129760NINDS NIH HHS R01 NS131606
6 · The paper itself

Abstract

purposeBrain tissue hypoxia and metabolic dysfunction are common in patients with subarachnoid hemorrhage (SAH) and may worsen prognosis. We aimed to assess the impact of episodes of low brain tissue partial pressure of oxygen (PbtO

methodsThis is a multicentric retrospective cohort study of SAH patients admitted to 5 neurocritical care units who required invasive multimodal neuromonitoring. The relationship between episodes of low PbtO

resultsWe included 232 SAH patients with a median of 117 (IQR 77-154) h of monitoring per patient. The color-coded plot illustrated that combined episodes of low PbtO

conclusionsIn this study, low PbtO

Indexed as

Hypoxia, BrainSubarachnoid HemorrhageAdultAgedBrainCohort StudiesFemaleGlasgow Outcome ScaleHumansMaleMicrodialysisMiddle AgedPartial PressurePrognosisPyruvic AcidRetrospective StudiesPyruvic AcidBrain metabolismBrain oxygenationInvasive multimodal monitoringStroke

Identifiers

PMID40261381
PMCPMC13056229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.